| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
3',5'-Bis-O-(triphenylMethyl)uridine manufacturers
|
| | 3',5'-Bis-O-(triphenylMethyl)uridine Basic information |
| Product Name: | 3',5'-Bis-O-(triphenylMethyl)uridine | | Synonyms: | 3',5'-Di-O-trityluridine;NSC 96000;Uridine, 3',5'-bis-O-(triphenylmethyl)-;1-((2R,3R,4S,5R)-3-hydroxy-4-(trityloxy)-5-((trityloxy)methyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;3',5'-Bis-O-(triphenylmethyl)uridine | | CAS: | 4710-75-2 | | MF: | C47H40N2O6 | | MW: | 728.83 | | EINECS: | | | Product Categories: | | | Mol File: | 4710-75-2.mol |  |
| | 3',5'-Bis-O-(triphenylMethyl)uridine Chemical Properties |
| Melting point | 135-145 °C | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 9.39±0.10(Predicted) |
| | 3',5'-Bis-O-(triphenylMethyl)uridine Usage And Synthesis |
| Uses | 3′,5′-Bis-O-(triphenylmethyl)uridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. | | References | [1] Connolly GP, et al. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20(5):218-25. DOI:10.1016/s0165-6147(99)01298-5 |
| | 3',5'-Bis-O-(triphenylMethyl)uridine Preparation Products And Raw materials |
|